PreprintArticleVersion 1Preserved in Portico This version is not peer-reviewed
Development and Characterization of Chitosan-Based Spray-Dried Solid Dispersions of Apigenin: 3D Printed Shell-Pill for Improved Efficacy of Model Flavonoid
Version 1
: Received: 17 April 2023 / Approved: 18 April 2023 / Online: 18 April 2023 (03:35:42 CEST)
How to cite:
Alali, A. S.; Ahmed, M.; Fatima, F.; Anwer, M. K.; Ibnauf, M.; Patel, J. Development and Characterization of Chitosan-Based Spray-Dried Solid Dispersions of Apigenin: 3D Printed Shell-Pill for Improved Efficacy of Model Flavonoid. Preprints2023, 2023040470. https://doi.org/10.20944/preprints202304.0470.v1
Alali, A. S.; Ahmed, M.; Fatima, F.; Anwer, M. K.; Ibnauf, M.; Patel, J. Development and Characterization of Chitosan-Based Spray-Dried Solid Dispersions of Apigenin: 3D Printed Shell-Pill for Improved Efficacy of Model Flavonoid. Preprints 2023, 2023040470. https://doi.org/10.20944/preprints202304.0470.v1
Alali, A. S.; Ahmed, M.; Fatima, F.; Anwer, M. K.; Ibnauf, M.; Patel, J. Development and Characterization of Chitosan-Based Spray-Dried Solid Dispersions of Apigenin: 3D Printed Shell-Pill for Improved Efficacy of Model Flavonoid. Preprints2023, 2023040470. https://doi.org/10.20944/preprints202304.0470.v1
APA Style
Alali, A. S., Ahmed, M., Fatima, F., Anwer, M. K., Ibnauf, M., & Patel, J. (2023). Development and Characterization of Chitosan-Based Spray-Dried Solid Dispersions of Apigenin: 3D Printed Shell-Pill for Improved Efficacy of Model Flavonoid. Preprints. https://doi.org/10.20944/preprints202304.0470.v1
Chicago/Turabian Style
Alali, A. S., Mutasim Ibnauf and Jamel Patel. 2023 "Development and Characterization of Chitosan-Based Spray-Dried Solid Dispersions of Apigenin: 3D Printed Shell-Pill for Improved Efficacy of Model Flavonoid" Preprints. https://doi.org/10.20944/preprints202304.0470.v1
Abstract
This study aimed to develop chitosan-based apigenin spray dried solid dispersion using 1:1,1:1.5,1:2 w/w ratios. The results of process yield and drug assay were found to be (87.5%, 94.2%, and 95.86%), (95.2 ±1.34%), (99.5 ±0.85%), and (97.6 ±2.42%), respectively, for AC1, AC2, and AC3. Flow properties indicate the free flow of powders. FTIR revealed compatibility among chitosan and apigenin, and DSC and XRD showed prepared solid dispersion was on a molecular level and available in amorphous. In contrast, SEM images reflect irregular block and near-spherical shape elongated particles in the selected AC2. The antimicrobial examination reflects that AC2 was more effective against Gram-positive, negative, and fungal strains. AC2 SDSDs has more anti-oxidant property compared to pure flavonoid (AGN). Anti-proliferative activity against A549 lung cancer cell lines showed better anti-cancer activity by AC2 SDSDs. The selected AC2 SDSD filled in a 3D shell pill and further characterized for 3D shell pill for dissolution profiles and stability studies. The product has sustained release and similar release profiles after three months of storage. The findings suggest that the AC2 SDSDs may be a promising candidate for further development as a 3D printed drug delivery system for treating multiple disease conditions using model flavonoid- apigenin.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
